AP/AC | |||||||||
---|---|---|---|---|---|---|---|---|---|
Continuation (A) n = 19, n (%) | Interruption (B) n = 18, n (%) | Control (C) n = 137, n (%) | p value | ||||||
A vs B | A vs C | B vs C | |||||||
Median age (range) | 77 | (57–89) | 81 | (58–90) | 72 | (38–90) | 0.14 | 0.12 | 0.00322 |
Sex | |||||||||
Male | 17 | (88%) | 14 | (78%) | 97 | (71%) | 0.40 | 0.10 | 0.78 |
Female | 2 | (12%) | 4 | (22%) | 40 | (29%) | |||
Tumor size | |||||||||
< 1 cm | 10 | (53%) | 8 | (44%) | 71 | (52%) | 0.75 | 1.0 | 0.62 |
≥ 1 cm | 9 | (47%) | 10 | (56%) | 66 | (48%) | |||
Tumor number | |||||||||
Single | 11 | (58%) | 12 | (67%) | 71 | (52%) | 0.74 | 0.81 | 0.32 |
Multiple | 8 | (42%) | 6 | (33%) | 66 | (48%) | |||
T classification at TURBT | |||||||||
pT0–a | 8 | (42%) | 7 | (39%) | 53 | (39%) | 0.43 | 0.71 | 0.35 |
pT1 | 9 | (47%) | 10 | (56%) | 59 | (43%) | |||
Min. pT2 | 2 | (11%) | 1 | (5%) | 25 | (18%) | |||
De novo | 10 | (53%) | 10 | (56%) | 83 | (61%) | >0.95 | 0.62 | 0.80 |
Recurrence | 9 | (47%) | 8 | (44%) | 54 | (39%) |